For: | Maurya DK, Bandekar M, Sandur SK. Soluble factors secreted by human Wharton’s jelly mesenchymal stromal/stem cells exhibit therapeutic radioprotection: A mechanistic study with integrating network biology. World J Stem Cells 2022; 14(5): 347-361 [PMID: 35722198 DOI: 10.4252/wjsc.v14.i5.347] |
---|---|
URL: | https://www.wjgnet.com/1948-0210/full/v14/i5/347.htm |
Number | Citing Articles |
1 |
Prashasti Sharma, Dharmendra Kumar Maurya. Wharton’s jelly mesenchymal stem cells: Future regenerative medicine for clinical applications in mitigation of radiation injury. World Journal of Stem Cells 2024; 16(7): 742-759 doi: 10.4252/wjsc.v16.i7.742
|
2 |
Kate Hurley, Rachel Clow, Ashok Jadhav, Edouard I. Azzam, Yi Wang. Mitigation of acute radiation syndrome (ARS) with human umbilical cord blood. International Journal of Radiation Biology 2024; 100(3): 317 doi: 10.1080/09553002.2023.2277372
|
3 |
Dharmendra Kumar Maurya, Santosh Kumar Sandur. Future Perspectives of Wharton’s Jelly Mesenchymal Stem Cells and their
Soluble Factors in Radioprotection. Current Stem Cell Research & Therapy 2024; 19(6): 781 doi: 10.2174/1574888X18666230119103905
|